[1]方铃铃,张如棉,林玥宏,等.中医药论治胰岛素抵抗的研究进展[J].医学信息,2025,38(03):188-192.[doi:10.3969/j.issn.1006-1959.2025.03.039]
　FANG Lingling,ZHANG Rumian,LIN Yuehong,et al.Research Progress of Traditional Chinese Medicine in the Treatment of Insulin Resistance[J].Journal of Medical Information,2025,38(03):188-192.[doi:10.3969/j.issn.1006-1959.2025.03.039]
点击复制

中医药论治胰岛素抵抗的研究进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年03期
页码:
188-192
栏目:
综述
出版日期:
2025-02-01

文章信息/Info

Title:
Research Progress of Traditional Chinese Medicine in the Treatment of Insulin Resistance
文章编号:
1006-1959（2025）03-0188-05
作者:
方铃铃1; 张如棉1; 林玥宏2; 蔡 虹1; 章 亭3
1.福建中医药大学附属厦门中医院/厦门市中医院肝一科，福建 厦门 361009；2.厦门弘爱医院肝病科，福建 厦门 361016；3.福建中医药大学附属厦门中医院/厦门市中医院科教科，福建 厦门 361015
Author(s):
FANG Lingling1;  ZHANG Rumian1;  LIN Yuehong2;  CAI Hong1;  ZHANG Ting3
1.The First Department of Hepatology, Xiamen Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine/Xiamen Hospital of Traditional Chinese Medicine, Xiamen 361009, Fujian, China;2.Department of Hepatology, Xiamen Humanity Hospital, Xiamen 361016, Fujian, China;3.Department of Science and Education, Xiamen Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine/Xiamen Hospital of Traditional Chinese Medicine, Xiamen 361015, Fujian, China
关键词:
胰岛素抵抗; 消渴; 中医药
Keywords:
Insulin resistance;  Consumptive thirst;  Traditional Chinese medicine
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2025.03.039
文献标志码:
A
摘要:
胰岛素抵抗（IR）作为多种代谢性疾病及心脑血管疾病的发病基础，其发病机制复杂，治疗也较为困难，已逐渐成为医学界关注的重点。中医认为本病主要的病因可以概括为先天不足、后天失调；病机总以阴虚为本、燥热为标，后逐渐发展为脾、肝、肾等诸脏亏虚；中医药治疗多从此病机入手，贯彻“治求其本”的原则辨证施治。许多研究表明中医药可以通过多种机制改善胰岛素抵抗，且有毒副作用少、安全性高等独特优势，故本文将从中医内治及中医外治两大方面综合论述近些年中医药改善胰岛素抵抗的研究进展，以期为临床治疗胰岛素抵抗提供新思路。
Abstract:
Insulin resistance (IR), as the basis for the pathogenesis of a variety of metabolic diseases and cardiovascular and cerebrovascular diseases, has a complex pathogenesis and difficult treatment, and has gradually become the focus of medical attention. Traditional Chinese medicine believes that the main causes of this disease can be summarized as congenital insufficiency and acquired disorders; the pathogenesis is always based on yin deficiency and dry heat, and then gradually develops into deficiency of spleen, liver, kidney and other organs; Traditional Chinese medicine treatment mostly starts from this disease mechanism, and implements the principle of "cure and seek its root". Many studies have shown that traditional Chinese medicine can improve insulin resistance through a variety of mechanisms, and has the unique advantages of few toxic side effects and high safety, so this article will comprehensively discuss the research progress of traditional Chinese medicine in the improvement of insulin resistance in recent years from two aspects: internal treatment of traditional Chinese medicine and external treatment of traditional Chinese medicine, in order to provide new ideas for the clinical treatment of insulin resistance.

参考文献/References:

[1]中华医学会糖尿病学分会胰岛素抵抗学组(筹).胰岛素抵抗评估方法和应用的专家指导意见[J].中华糖尿病杂志,2018,10(6):377-385.[2]中华医学会糖尿病学分会. 胰岛素抵抗相关临床问题专家共识(2022版)[J].中华糖尿病杂志,2022,14(12):1368-1379.[3]中医出版中心整理.灵枢经[M].北京:人民卫生出版社,2012:19,103,112,114.[4]赵献可.医贯[M].北京:人民卫生出版社,2005:94.[5]黄帝内经素问[M].北京:人民卫生出版社,2005:48,92．[6]刘完素.河间六书[M].山西:山西科学技术出版社,2010:216,217.[7]宋·陈言.三因极一病证方论[M].北京:人民卫生出版社,2007.[8]张介宾.景岳全书[M].北京:人民卫生出版社,2007.[9]梁艳梅,付灵梅.从“阳化气,阴成形”理论浅谈糖尿病证治[J].中医药导报,2017,23(5):76-77.[10]刘雪梅,李南,刘冬梅.五味消渴汤联合耳穴压豆治疗气阴两虚证2型糖尿病临床疗效观察[J].实用医院临床杂志,2021,18(5):32-35.[11]金惠英,金京国.健脾滋阴消渴方治疗2型糖尿病气阴两虚证临床疗效及对胰岛素敏感性和胰岛β细胞功能的影响[J].中国中医药信息杂志,2019,26(7):35-39.[12]尧波.降糖消渴方对2型糖尿病患者血糖水平及胰岛素抵抗的影响[J].药品评价,2022,19(12):757-759.[13]倪晓春,朱晓宏.益气降糖方联合二甲双胍治疗气阴两虚型2型糖尿病胰岛素抵抗疗效观察[J].四川中医,2020,38(8):126-129.[14]庞宇慧,张少飞,王会军,等.芪黄降糖胶囊联合二甲双胍治疗2型糖尿病的疗效及对胰岛素抵抗的影响研究[J].徐州医科大学学报,2020,40(3):199-202.[15]隋·杨上善.黄帝内经太素[M].北京:中医古籍出版社,2016:249.[16]夏中颖,晏军,夏佳欣,等.刘燕池滋阴清热法辨治消渴病经验[J].中华中医药杂志,2022,37(10):5770-5773.[17]张意,赵博,王飞,等.清热解毒方联合二甲双胍治疗代谢综合征合并胰岛素抵抗的临床研究[J].遵义医科大学学报,2021,44(2):212-217,223.[18]符绩军,刘志勇,胡敏,等.黄连解毒汤联合低热量饮食对新诊断肥胖2型糖尿病血糖及胰岛素分泌影响的研究[J].中华中医药学刊,2022,40(12):143-145.[19]潘赏赏,李力,王娴.黄连温胆汤联合盐酸二甲双胍对湿热内蕴型早期2型糖尿病患者的临床疗效[J].中成药,2021,43(2):557-559.[20]刘舟,李月碧,张卫华,等.黄连温胆汤对糖尿病大鼠海马胰岛素抵抗和神经发生受损的改善作用[J].中国实验方剂学杂志,2015,21(18):115-119.[21]李东风.湿热困脾型T2DM肥胖患者应用黄连温胆汤加味治疗对其糖脂代谢水平及胰岛素抵抗的影响[J].现代诊断与治疗,2020,31(24):3873-3875.[22]徐江红,郝永蕾,吴雪红,等.从李东垣阴火理论论治糖尿病胰岛素抵抗[J].光明中医,2020,35(13):2071-2073.[23]韩煦,姚政,李俊燕,等.健脾清化方改善2型糖尿病大鼠肠道胰岛素抵抗[J].中华中医药杂志,2019,34(7):2973-2977.[24]钱宇洁.加味七味白术散改善脾虚型2型糖尿病胰岛素抵抗的临床观察[D].济南:山东中医药大学,2022.[25]罗思聪,郭永宁,蔡海荣,等.疏肝温胆汤对胰岛素抵抗肥胖大鼠糖脂代谢和炎症因子的影响[J].广州中医药大学学报,2021,38(4):773-778.[26]雷霏,高彩霞.小柴胡汤加减对代谢相关性脂肪性肝病患者肝功能及胰岛素抵抗的影响[J].陕西中医,2022,43(7):890-893.[27]邹耀武.菖蒲郁金汤加减对2型糖尿病合并非酒精性脂肪肝患者糖脂代谢异常及胰岛素抵抗的影响[J].现代中西医结合杂志,2022,31(3):389-392.[28]卢福恭,王汉卿,付慧玲,等.消渴病历代学术考证[J].辽宁中医药大学学报,2018,20(5):66-68.[29]叶天士.临证指南医案[M].北京:中国中医药出版社,2008.[30]仝小林,刘文科.论膏浊病[J].中医杂志,2011,52(10):816-818.[31]张卫欢,李秋云,杨春伟,等.大柴胡汤加减联合利拉鲁肽对肥胖2型糖尿病患者胰岛素抵抗、β-细胞功能和低度炎症反应的影响[J].现代中西医结合杂志,2018,27(1):23-26,30.[32]廉洁,吴深涛.吴深涛对浊毒的新认识[J].中国中医药信息杂志,2014,21(5):104-105.[33]王晓璐,周静,吴深涛.化浊解毒方治疗肥胖胰岛素抵抗浊毒内蕴证[J].中医学报,2022,37(11):2434-2439.[34]张瀚文,康学东,余臣祖,等.解毒化浊方治疗2型糖尿病合并非酒精性脂肪肝的临床研究[J].实用中西医结合临床,2015,15(5):5-7,93.[35]侯盈文,林少怡,胡子衡,等.王不留行籽耳穴埋豆法用于偏头痛的干预效果[J].慢性病学杂志,2023,24(1):119-121.[36]李妍,郝松莉,张春兰,等.耳穴压籽治疗青春期超重/肥胖多囊卵巢综合征临床观察[J].现代中西医结合杂志,2018,27(35):3877-3879,3906.[37]黄玮,刘煊,张卫蕙,等.王不留行子耳穴贴压联合常规治疗对超重型2型糖尿病患者的临床疗效[J].中成药,2020,42(12):3369-3371.[38]李玉嫦,冯婷,容春凤,等.耳穴揿针联合二甲双胍对痰湿型多囊卵巢综合征患者胰岛素抵抗的影响[J].中医外治杂志,2021,30(2):59-61.[39]王聪.俞募埋线对肥胖2型糖尿病患者胰岛素抵抗的影响[D].咸阳:陕西中医药大学,2022.[40]张国辉,李芳莉,王进东.长针透刺埋线对痰湿体质肥胖患者胰岛素抵抗和氧化应激指标的影响[J].中医临床研究,2022,14(22):59-61.[41]万红,燕树勋,闫诏,等.穴位埋线治疗胃热湿阻型单纯性肥胖：随机对照研究[J].中国针灸,2022,42(2):137-142.[42]高天姣,马德慧,韩怡然,等.基于SIRT1/PGC-1α通路探讨腹部推拿对肥胖2型糖尿病模型大鼠抗炎作用机制研究[J].时珍国医国药,2021,32(8):2028-2030.[43]张欣,刘明军,吴兴全,等.运腹通经推拿法对肥胖大鼠骨骼肌SIRT1/PGC-1α通路蛋白及其mRNA表达影响的实验研究[J].中华中医药学刊,2020,38(11):22-25.[44]张晓林.“运腹通经”推拿法对肥胖肝脏胰岛素抵抗的辅助临床效应及差异表达基因研究[D].长春:长春中医药大学,2022.

相似文献/References:

[1]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
　LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Journal of Medical Information,2018,31(03):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[2]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(03):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[3]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、 白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
　XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Journal of Medical Information,2019,32(03):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[4]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系 及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
　LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms and Treatment[J].Journal of Medical Information,2019,32(03):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
[5]赵 猛,孙 娟,褚 璇.苯扎贝特改善2型糖尿病合并高甘油三酯血症患者 胰岛素抵抗的临床分析[J].医学信息,2019,32(17):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
　ZHAO Meng,SUN Juan,CHU Xuan.Clinical Analysis of Bezafibrate in Improving Insulin Resistance in Patients with Type 2 Diabetes Mellitus Complicated with Hypertriglyceridemia[J].Journal of Medical Information,2019,32(03):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
[6]李淑娟,王爱芹,杨学军,等.子宫内膜息肉发病相关危险因素临床分析[J].医学信息,2019,32(13):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
　LI Shu-juan,WANG Ai-qin,YANG Xue-jun,et al.Clinical Analysis of Risk Factors Related to the Incidence of Endometrial Polyps[J].Journal of Medical Information,2019,32(03):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
[7]陈 月,任 伟.胰岛素抵抗与肌少症关系的研究[J].医学信息,2019,32(23):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
　CHEN Yue,REN Wei.Study on the Relationship Between Insulin Resistance and Sarcopenia[J].Journal of Medical Information,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
[8]李 玲,宋光耀.健康体检者胰岛素抵抗与血脂异常的相关性及血脂最佳分界值的探讨[J].医学信息,2020,33(01):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]
　LI Ling,SONG Guang-yao.Correlation Between Insulin Resistance and Dyslipidemia and the Best Cut-off Value of Blood Lipids in Healthy People[J].Journal of Medical Information,2020,33(03):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]
[9]张晴晴,张瑞霞.Irisin的生理效应及其循环水平的影响因素[J].医学信息,2020,33(02):36.[doi:10.3969/j.issn.1006-1959.2020.02.010]
　ZHANG Qing-qing,ZHANG Rui-xia.The Physiological Effect of Irisin and the Influencing Factors of its Circulation Level[J].Journal of Medical Information,2020,33(03):36.[doi:10.3969/j.issn.1006-1959.2020.02.010]
[10]禤文婷,陈丽霞,黎美金,等.Galectin-2在妊娠期糖尿病患者中的表达及其与胰岛素抵抗的关系[J].医学信息,2020,33(16):72.[doi:10.3969/j.issn.1006-1959.2020.16.022]
　XUAN Wen-ting,CHEN Li-xia,LI Mei-jin,et al.The Expression of Galectin-2 in Patients with Gestational Diabetes and Its Relationship with Insulin Resistance[J].Journal of Medical Information,2020,33(03):72.[doi:10.3969/j.issn.1006-1959.2020.16.022]

更新日期/Last Update: 1900-01-01